Loading...

Personalis, Inc.

PSNL•NASDAQ
Healthcare
Medical - Diagnostics & Research
$6.10
$0.20(3.39%)
U.S. Market opens in 23h 5m

Personalis, Inc. (PSNL) Stock Overview

Explore Personalis, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap541.7M
P/E Ratio-6.90
EPS (TTM)$-0.91
ROE-0.39%
Fundamental Analysis

AI Price Forecasts

1 Month$8.42
3 Months$8.85
1 Year Target$11.47

PSNL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Personalis, Inc. (PSNL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 38.90, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.47.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.90 and a market capitalization of 541.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.39%
5-Day Change
-12.36%
1-Month Change
-21.59%
3-Month Change
-40.02%
6-Month Change
-36.98%
Year-to-Date (YTD) Change
-23.37%
1-Year Change
59.27%
3-Year Change
158.47%
5-Year Change
-74.85%
All-Time (Max) Change
-78.59%

Contact Information

https://www.personalis.com
650 752 1300
1330 O’Brien Drive, Fremont, CA, 94025

Company Facts

228 Employees
IPO DateJun 20, 2019
CountryUS
Actively Trading

Frequently Asked Questions